Articles On Integral Diagnostics (ASX:IDX)

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7895.00 – 70.00 – 0.88% S&P ASX 200 7962.30...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are indicating a positive session might lay ahead for the Australian sha...

Highlights: Market shifts present scenarios where select small-cap stocks show pricing differences relative to their fundamentals. Business sectors such as healthcare, mining, and energy continue to exhibit operational developmen...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US President Donald Trump said Thursday that he would allow Mexico and Canada to avo...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck By Rudi Filapek-Vandyck, EditorWithin the space of a number of weeks...

A key FDA quality control lab will remain open, while a judge halts DOGE’s plans to cull billions of research grants Cochlear and Resmed win an upgrade after their post-results share thumping Dissident holder sells out after Percheron CEO...

The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA  Pacific Edge was...

Healthcare analysts say Neuren shares should be worth more than double what they are Biotech sector retreats in February, despite some record results Dimerix pockets $3.2 million payment from Japanese partner   Some healthcare analysts be...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((29M)) - 29Met...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

The Integral Diagnostics Ltd (ASX: IDX) share price is having a day to forget on Wednesday. In morning trade, the ASX healthcare stock is down 30% to $2.00. This follows the release of the medical imaging services provider's half year resul...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are suggesting another cautious, slightly weaker opening for the ASX tod...

Looking to buy a few ASX small-cap shares to potentially help turbocharge your portfolio returns in 2025? Then Lucas Goode, a portfolio manager for the IML Australian Smaller Companies Fund, has three companies you may wish to run your slid...

Headlines ASX200 hits a new peak amid positive market sentiment. Insider actions offer insights into small-cap opportunities. Spotlight on Healius, Integral Diagnostics, and K&S Corporation. Promising Australian Small-Caps in...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck By Rudi Filapek-Vandyck, Editor Morningstar's selection of Best Buys...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck By Rudi Filapek-Vandyck, Editor As is custom this time of the year, f...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

S&P/ASX All Ords (ASX: XAO) shares fell 3.2% in December in an unusually weak final month of the year. Meantime, some brokers changed their ratings on various ASX stocks before heading off on holidays. Here are six ASX All Ords sh...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck Earlier this month we asked investors to send in their questions. Tod...

A “valuation disconnect” between groups of larger stocks on the ASX versus their smaller counterparts will throw up plenty of value opportunities in 2025, helped by an overdue pullback in global sharemarkets. That’s the view of the small an...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck Today's update includes: -A Conflict In Waiting?-Banks And Super Fund...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Greg Peel Pending MRI deregulation is behind the now approved merger of Integral Diagnosti...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US Equities had a weak session, but nothing like the growth stocks sell-off that occ...

Integral Diagnostics (ASX:IDX), which operates diagnostic imaging services in Australia and New Zealand, has secured clearance from the Australian Competition and Consumer Commission (ACCC) for its proposed acquisition of Capitol Health (AS...

The latest round of broker upgrades on ASX All Ords shares are here and you may as well strap in because there's a few names to discuss. Brokers are bullish on companies ranging from the healthcare sector, to energy, to food, giving inv...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

ASX healthcare shares finished in the red on Friday, with the S&P/ASX 200 Health Care Index (ASX: XHJ) falling 1.11% while the S&P/ASX 200 Index (ASX: XJO) also tumbled 0.5%. In a recent note, fund manager IML identified th...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8118.00 – 52.00 – 0.64% S&P ASX 200 8160.00...

Jarden upgrades Integral Diagnostics after merger insights The broker highlights growth opportunities in imaging sector Australia’s deregulation boosts MRI access and revenue potential   The imaging sector is by no means the sexiest part...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Aidoc’s AI technology enhances radiology services at IDX, significantly improving...

  The major indexes wrapped up Wednesday just above the flatline, as rising tensions in the Middle East put pressure on the markets. The S&P 500 edged up 0.01 per cent to finish at 5,709.54, while the Nasdaq Composite rose 0.08 per cent...

The major indexes wrapped up Wednesday just above the flatline, as rising tensions in the Middle East put pressure on the markets. The S&P 500 edged up 0.01 per cent to finish at 5,709.54, while the Nasdaq Composite rose 0.08 per cent t...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

The Dow Jones Industrial Average climbed to a record high overnight, as Wall Street attempted to recover from a steep sell-off earlier this month. The 30-stock index gained 243.63 points, or 0.59 per cent, closing at a new record of 41,335....

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ADH)) - Adair...

ASX healthcare stocks showed mixed results following the release of their most recent financials on Tuesday. Three companies in particular stand out, with two finishing in the green and one in the red. Integral Diagnostics Ltd (ASX: I...

As the 2024 fiscal year reporting season progresses, several key players across different sectors have revealed their financial performance, showcasing a mix of resilience and challenges. Diagnostic imaging provider Capitol Health, energy c...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

As another ASX reporting season unfolds, investors and financial analysts alike will spend the next several weeks keenly focused on dissecting company balance sheets to gauge the financial health and performance of ASX companies. We'll...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

Highlights:  ASX 200 futures fall 1.09%, mirroring losses in major US indices and mixed global economic updates.  Big Tech stocks showed mixed results overnight, with Meta and Nvidia gaining, while Apple, Alphabet, and Amazon decline...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

The Bapcor Ltd (ASX: BAP) share price is having a tough time on Tuesday. In morning trade, the ASX 200 stock is down 4% to $4.85. What's going on? Investors have been hitting the sell button today after the auto parts retailer released a co...

Chalice Mining Ltd (ASX: CHN) shares are catching the eye on Wednesday. In morning trade, the ASX mining stock is up 8% to $1.64. Why is this ASX mining stock racing higher? Investors have been scrambling to buy the company's shares this mo...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...